Demographic Characteristics and SGLT2 Inhibitor Use Among Patients With Diabetes

This cohort study evaluates whether inequities in race/ethnicity, gender, and socioeconomic status exist in sodium-glucose cotransporter 2 (SGLT2) inhibitor use among US patients with type 2 diabetes.

Read the full article here

Related Articles